• Fri news: Eisai/Biogen Alzheimers med. BMS earnings beat. Big Pharma unfazed by IRA. Indivior opioid settlement. Abbott CGM recall. —http://bit.ly/w28kSd — See more on our front page

Low salary and no company car

This is a house of cards. Everything is being built to be sold. That is why we are heavy on metrics and light on incentives. Just look at the lack of company cars. That would be a long term investment. They have the capital to pay higher salaries & cars but they chose to keep it all low so their P&L will look better to potential buyers.
Who would buy it